---
title: ProRelix Research vs SPRIM PRO
slug_a: prorelixresearch
slug_b: sprim-pro
site: cro
review_signal_gate: closed
canonical_path: /compare/prorelixresearch/sprim-pro
---

# ProRelix Research vs SPRIM PRO

Side-by-side profile data from each company listing on this directory.

## ProRelix Research

- Profile: [/companies/prorelixresearch](/companies/prorelixresearch)

ProRelix Research — ProRelix Research supports Phase 1–4 clinical trials across pharmaceutical, biotechnology, and medical device sectors, offering clinical trial project management, data management, and medical writing services in compliance with ICH and GCP principles across the US, India, Europe, and Australia.

Services: 9. Modalities: 0. Indications: 0. Locations: 4. Certifications: 0. The strongest documented coverage currently appears in services (9).

### Services

- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Data Management & eClinical
- Pharmacovigilance & Drug Safety
- Medical Writing
- Regulatory Affairs

### Modalities

- Data not yet provided.

### Indications

- Data not yet provided.

### Phases

- Phase I
- Phase II
- Phase III
- Phase IV

### Sourcing models

- Full-Service Outsourcing (FSO)

## SPRIM PRO

- Profile: [/companies/sprim-pro](/companies/sprim-pro)

SPRIM PRO — Clinical trial and strategic consulting CRO offering innovation-enabled trial solutions, digital training, patient engagement programs, and regulatory consulting across multiple therapeutic areas including oncology, CNS, cardiovascular, and rare disease.

Services: 10. Modalities: 0. Indications: 9. Locations: 4. Certifications: 0. The strongest documented coverage currently appears in services (10).

### Services

- Clinical Trial Services
- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Data Management & eClinical
- Medical Writing
- Regulatory Affairs
- US FDA Regulatory Strategy

### Modalities

- Data not yet provided.

### Indications

- Oncology
- Immunology
- Neurology
- Cardiovascular
- Infectious Disease
- Rare Disease
- Dermatology
- Gastroenterology
- Women's Health

### Phases

- Phase I
- Phase II
- Phase III
- Phase IV

### Sourcing models

- Full-Service Outsourcing (FSO)